Topics

FDA Action Alert: Regeneron, Sanofi, Celgene

20:00 EDT 23 Jun 2019 | BioSpace

July looks to be a quiet month for the U.S. Food and Drug Administration (FDA), and it sure looks like the agency is trying to get a lot of work done before the July 4 holiday. Here’s a look at the many approvals scheduled for this week.

Original Article: FDA Action Alert: Regeneron, Sanofi, Celgene

NEXT ARTICLE

More From BioPortfolio on "FDA Action Alert: Regeneron, Sanofi, Celgene"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...